Lataa...
Evidence-based review of data on the combination inhaler umeclidinium/vilanterol in patients with COPD
The use of inhaled, fixed-dose, long-acting muscarinic antagonists (LAMA) combined with long-acting, beta(2)-adrenergic receptor agonists (LABA) has become a mainstay in the maintenance treatment of chronic obstructive pulmonary disease (COPD). One of the fixed-dose LAMA/LABA combinations is the dry...
Tallennettuna:
| Julkaisussa: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6559138/ https://ncbi.nlm.nih.gov/pubmed/31239659 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S191845 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|